Sofosbuvir-Based Therapy for Chronic Hepatitis C Infection in Children with Malignancies

被引：0
|
作者：
Jayabose, S. [1 ]
Palaniappan, A. [1 ]
Iyer, N. [1 ]
Viswanathan, K. [1 ]
Annamalai, A. [1 ]
机构：
[1] Meenakshi Mission Hosp & Res Ctr, Pediat Hematol Oncol, Madurai, Tamil Nadu, India
来源：
PEDIATRIC BLOOD & CANCER | 2017年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O-108
引用
收藏
页码：S62 / S62
页数：1
相关论文
共 50 条
  • [1] Sofosbuvir-based therapy in patients with chronic hepatitis C virus infection and malignancies: A prospective study of 143 patients.
    Torres, Harrys A.
    Economides, Minas P.
    Kyvernitakis, Andreas
    Mahale, Parag
    Hosry, Jeff
    Naing, Aung
    Turturro, Francesco
    Kaseb, Ahmed Omar
    Raad, Issam I.
    Granwehr, Bruno Palma
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] Tolerance and Outcomes of Sofosbuvir-Based Therapy for Chronic Hepatitis C
    George, Khalid
    Weick, Alexander
    Moonka, Dilip
    Jafri, Syed-Mohammed
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S171 - S171
  • [3] Sofosbuvir-based therapy in patients with chronic hepatitis C virus infection and malignancies - A prospective observational study of 136 patients
    Torres, H. A.
    Economides, M. P.
    Kyvernitakis, A.
    Mahale, P.
    Hosry, J.
    Jiang, Y.
    Kaseb, A.
    Raad, I.
    Granwehr, B. P.
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S506 - S506
  • [4] Renal profile of chronic hepatitis C patients with sofosbuvir-based therapy
    El-Sayed, Mohammad
    Abdellatif, Zeinab
    Elsharkawy, Aisha
    El Kassas, Mohamed
    Abd Elmoniem, Reham
    Marzouk, Amaal
    Fouad, Rabab
    Esmat, Gamal
    Alem, Shereen Abdel
    [J]. INFECTION, 2020, 48 (06) : 913 - 922
  • [5] Renal profile of chronic hepatitis C patients with sofosbuvir-based therapy
    Mohammad El-Sayed
    Zeinab Abdellatif
    Aisha Elsharkawy
    Mohamed El Kassas
    Reham Abd Elmoniem
    Amaal Marzouk
    Rabab Fouad
    Gamal Esmat
    Shereen Abdel Alem
    [J]. Infection, 2020, 48 : 913 - 922
  • [6] Efficacy and safety of sofosbuvir-based therapy for chronic hepatitis C infection in “real-life” cohort
    Mehta R.
    Kabrawala M.
    Nandwani S.
    Tekriwal R.
    Nandaniya P.
    Shah M.
    Bhayani V.
    [J]. Indian Journal of Gastroenterology, 2016, 35 (6) : 459 - 464
  • [7] Efficacy and safety of sofosbuvir-based therapy for aged patients with chronic hepatitis C
    Urabe, Ayako
    Sakamori, Ryotaro
    Tatsumi, Tomohide
    Yakushijin, Takayuki
    Yamada, Ryoko
    Oze, Tsugiko
    Morishita, Naoki
    Tahata, Yuki
    Hosui, Atsushi
    Miyagi, Takuya
    Doi, Yoshinori
    Kaneko, Akira
    Oshita, Masahide
    Hagiwara, Hideki
    Yamada, Yukinori
    Tamura, Shinji
    Imai, Yasuharu
    Furuta, Kunimaro
    Hikita, Hayato
    Hiramatsu, Naoki
    Hayashi, Norio
    Takehara, Tetsuo
    [J]. HEPATOLOGY, 2016, 64 : 996A - 997A
  • [8] Effectiveness and safety of sofosbuvir-based therapy against chronic hepatitis C infection after successful kidney transplantation
    Musialik, Joanna
    Kolonko, Aureliusz
    Kwiecien, Katarzyna
    Owczarek, Aleksander J.
    Wiecek, Andrzej
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2019, 21 (03)
  • [9] Efficacy and safety of sofosbuvir-based triple therapy in hepatitis C genotype 4 infection
    Wehmeyer, Malte H.
    Jordan, Sabine
    Lueth, Stefan
    Hartl, Johannes
    Stoehr, Albrecht
    Eissing, Christiane
    Lohse, Ansgar W.
    Petersen, Joerg
    Buggisch, Peter
    zur Wiesch, Julian Schulze
    [J]. DIGESTIVE AND LIVER DISEASE, 2015, 47 (09) : 811 - 814
  • [10] Impact of Sofosbuvir-Based Therapy on Liver Transplant Candidates with Hepatitis C Virus Infection
    Dellay, Bethany
    Sexter, Anne
    Wang, Jeffrey H.
    Hess, Gregory P.
    Kim, W. Ray
    Israni, Ajay K.
    [J]. PHARMACOTHERAPY, 2019, 39 (04): : 424 - 432
12345